Side-by-side financials for ABOS and BIIB. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABOS | BIIB |
|---|---|---|
| Market cap | - | $29.52 B |
| US-listed rank | - | #472 |
| Revenue (latest FY) | - | $9.89B |
| Net income (latest FY) | -$121.33M | $1.29B |
| Net margin | - | 13.1% |
| P/E (trailing FY) | - | 22.8 |
| SEC filings | 336 | 2,690 |
Full pages: Acumen Pharmaceuticals, Inc. and BIOGEN INC., or browse the full rankings.